0003-3756Level 3
OPDIVO (nivolumab)
**Product type:** Human Prescription Drug
**Active ingredient:** NIVOLUMAB
**Strength:** 10 mg/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** E.R. Squibb & Sons, L.L.C.
**Marketing category:** BLA (BLA125554)
**Pharmacologic class:** Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0003-3756Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.